ACON Logo

Aclarion, Inc. (ACON) 

NASDAQ
Market Cap
$1.77M
Sector
Healthcare
Industry
Medical—Healthcare Information Services
Rank in Sector
408 of 774
Rank in Industry
17 of 32

Largest Insider Buys in Sector

ACON Stock Price History Chart

ACON Stock Performance

About Aclarion, Inc.

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.

Insider Activity of Aclarion, Inc.

Over the last 12 months, insiders at Aclarion, Inc. have bought $0 and sold $0 worth of Aclarion, Inc. stock.

On average, over the past 5 years, insiders at Aclarion, Inc. have bought $34,309 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1 shares for transaction amount of $1,000 was made by Thramann Jeffrey John (Executive Chairman) on 2023‑02‑16.

List of Insider Buy and Sell Transactions, Aclarion, Inc.

2023-02-16PurchaseExecutive Chairman
1
$1,000.00$1,000-26.29%
2022-12-29PurchaseChief Financial Officer
22,404.44
0.2978%
$0.45$10,000+10.57%
2022-12-29PurchaseChief Executive Officer
16,211
0.2623%
$0.54$8,807+10.57%
2022-12-28PurchaseChief Executive Officer
2,289
0.0375%
$0.42$961+44.79%
2022-04-21Purchase
11,000
0.2249%
$4.35$47,850-68.80%

Insider Historical Profitability

<0.0001%
Wesemann William
52736
0.52%
$0.1810<0.0001%
Lorbiecki John PaulChief Financial Officer
22404
0.2209%
$0.1810+10.57%
Ness BrentChief Executive Officer
19500
0.1923%
$0.1820+27.68%
Thramann Jeffrey JohnExecutive Chairman
1
0%
$0.1810<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.